APA

Zhang H., Liu K., Pu Q., Achab A., Ardolino M. J., Cheng M., Deng Y., Doty A. C., Ferguson H., Fradera X., Knemeyer I., Kurukulasuriya R., Lam Y., Lesburg C. A., Martinot T. A., McGowan M. A., Miller J. R., Otte K., Biju P. J., Sciammetta N., Solban N., Yu W., Zhou H., Wang X., Bennett D. J. & Han Y. (2019). Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy. : ACS medicinal chemistry letters.

Chicago

Zhang Hongjun, Liu Kun, Pu Qinglin, Achab Abdelghani, Ardolino Michael J, Cheng Mangeng, Deng Yongqi, Doty Amy C, Ferguson Heidi, Fradera Xavier, Knemeyer Ian, Kurukulasuriya Ravi, Lam Yu-Hong, Lesburg Charles A, Martinot Theodore A, McGowan Meredeth A, Miller J Richard, Otte Karin, Biju Purakattle J, Sciammetta Nunzio, Solban Nicolas, Yu Wensheng, Zhou Hua, Wang Xiao, Bennett David Jonathan and Han Yongxin. 2019. Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy. : ACS medicinal chemistry letters.

Harvard

Zhang H., Liu K., Pu Q., Achab A., Ardolino M. J., Cheng M., Deng Y., Doty A. C., Ferguson H., Fradera X., Knemeyer I., Kurukulasuriya R., Lam Y., Lesburg C. A., Martinot T. A., McGowan M. A., Miller J. R., Otte K., Biju P. J., Sciammetta N., Solban N., Yu W., Zhou H., Wang X., Bennett D. J. and Han Y. (2019). Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy. : ACS medicinal chemistry letters.

MLA

Zhang Hongjun, Liu Kun, Pu Qinglin, Achab Abdelghani, Ardolino Michael J, Cheng Mangeng, Deng Yongqi, Doty Amy C, Ferguson Heidi, Fradera Xavier, Knemeyer Ian, Kurukulasuriya Ravi, Lam Yu-Hong, Lesburg Charles A, Martinot Theodore A, McGowan Meredeth A, Miller J Richard, Otte Karin, Biju Purakattle J, Sciammetta Nunzio, Solban Nicolas, Yu Wensheng, Zhou Hua, Wang Xiao, Bennett David Jonathan and Han Yongxin. Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy. : ACS medicinal chemistry letters. 2019.